The inhibition of this protein by Mdivi-1, studied both in vivo in apolipoprotein E (ApoE)-/- mice [184] and in vitro in HUVECs [185], resulted in athero-protective effects, which suggests its potential as a therapeutic target for multiple CVDs, including atherosclerosis [182,186]. The gene discussed is APOE; the disease is atherosclerosis.